Analystreport

Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $42.00 price target on the stock.

Evolent Health, Inc Class A  (EVH) 
Last evolent health, inc class a earnings: 2/25 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ir.evolenthealth.com